Addressing Functional Neurotoxicity Using the Microelectrode Array (MEA)
Early drug development requires tests for compound-induced neurotoxic effects, i.e., to investigate possible alterations of neuronal activity as a result of the test compound. In vivo and in vitro animal models transpire not to be overly predictive of neurotoxic effects in humans and furthermore are in contradiction to the efforts of the European Community to reduce the number of animal experiments. Consequently, alternatives to these animal model-based assays are currently being investigated. Human induced pluripotent stem cell (hiPSC)-derived neurons offer several advantages, including being of human origin and offering the possibility of developing disease models from patient-derived cells. The development of electrophysiological assays based on microelectrode array systems (MEA) allows one to study alterations of neuronal activity in samples of varying complexity ranging from single cells to neuronal networks. As a non-invasive method it supports not only acute but also long-term experiments for extended time periods. Here we describe how to record neuronal activity from neurons and provide exemplarily insights into a validation study for a commercially available hiPSC-derived neuronal cell type.
Key wordsMicroelectrode array MEA Multi-well Assay development Spike analysis Neuronal activity Threshold detection
- 5.Thomas CA, Springer PA, Loeb GE et al (1972) A miniature microelectrode array to monitor the bioelectric activity of cultured cells. Exp Cell Res 74:61–66. doi:10.1016/0014-4827(72)90481-8
- 8.Peri.4U – hiPSC Peripheral Neurons - AXIOGENESIS - iPSC Human Cardiomyocytes Neurons Hypertrophy Disease Model Cells. http://axiogenesis.com/products/neuronal-cells/peri-4u-hipsc-peripheral-neurons.html. Accessed 25 Feb 2016
- 29.EFSA (2008) Conclusion regarding the peer review of the pesticide risk assessment of the active substance mepiquat. EFSA Journal 6(7). http://dx.doi.org/10.2903%2Fj.efsa.2008.146r